SCHEMBL3733424

SCHEMBL3733424

CC(C)(C)OC(=O)N1CCC(C)(O)C1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM1A O60341 1/20 0.42
▸ PDE4A P27815 4/20 0.39
▸ PDE4B Q07343 4/20 0.39
▸ PDE4C Q08493 4/20 0.39
▸ PDE4D Q08499 4/20 0.39
▸ USP2 O75604 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ BUB1 O43683 1/20 0.37
▸ GRIN2B Q13224 1/20 0.36
▸ GRIN2C Q14957 1/20 0.36
▸ USP30 Q70CQ3 1/20 0.34
▸ CTSK P43235 1/20 0.34
▸ MAPT P10636 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ THRB P10828 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ DDB1 Q16531 1/20 0.34
▸ CRBN Q96SW2 1/20 0.34
▸ NR1H2 P55055 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL479856 0.85 KDM1A (0.43) KDM1APDE4APDE4BPDE4CPDE4D
SCHEMBL23388831 0.82 KDM1A (0.41) KDM1APDE4APDE4BPDE4CPDE4D
SCHEMBL20456330 0.81 KDM1A (0.43) KDM1APDE4APDE4BPDE4CPDE4D
SCHEMBL16413800 0.81 KDM1A (0.40) KDM1APDE4APDE4BPDE4CPDE4D
SCHEMBL25248764 0.81 KDM1A (0.40) KDM1APDE4APDE4BPDE4CPDE4D
SCHEMBL27192628 0.80 KDM1A (0.42) KDM1APDE4APDE4BPDE4CPDE4D
SCHEMBL25232243 0.79 KDM1A (0.41) KDM1APDE4APDE4BPDE4CPDE4D
SCHEMBL21425702 0.79 GRIN2B (0.41) KDM1APDE4APDE4BPDE4CPDE4D
SCHEMBL21408126 0.79 KDM1A (0.41) KDM1APDE4APDE4BPDE4CPDE4D
SCHEMBL18039806 0.78 KDM1A (0.39) KDM1APDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114031518-B Benzylamine or benzyl alcohol derivative and application thereof 成都海博为药业有限公司 2023-08-18 — — CN disclosed
US-8242285-B2 N-tert-butoxycarbonyl-2-pyrrolidinones and production method thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-08-14 — — US disclosed
US-20100280259-A1 N-Tert-Butoxycarbonyl-2-Pyrrolidinones and Production Method Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-11-04 — — US disclosed
US-20090163722-A1 N-TERT-BUTOXYCARBONYL-2-PYRROLIDINONES AND PRODUCTION METHOD THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-06-25 — — US disclosed
CN-101415676-A N-tert-butoxycarbonyl-2-pyrrolidinone compounds and method for producing the same SUMITOMO CHEMICAL CO (JP) 2009-04-22 — — CN disclosed
EP-2008999-A1 N-TERT-BUTOXYCARBONYL-2-PYRROLIDINONES AND PROCESS FOR PRODUCING THE SAME Sumitomo Chemical Company, Limited (JP) 2008-12-31 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090163722-A1 N-TERT-BUTOXYCARBONYL-2-PYRROLIDINONES AND PRODUCTION METHOD THEREOF TERT, CBR1, TELO2 KDM1A 247/4885PDE4A 4686/4885PDE4B 4683/4885
US-20100280259-A1 N-Tert-Butoxycarbonyl-2-Pyrrolidinones and Production Method Thereof TERT, CBR1, TELO2 KDM1A 247/4885PDE4A 4686/4885PDE4B 4683/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback